Does SORAFENIB Cause Reactive capillary endothelial proliferation? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Reactive capillary endothelial proliferation have been filed in association with SORAFENIB (sorafenib). This represents 0.1% of all adverse event reports for SORAFENIB.
5
Reports of Reactive capillary endothelial proliferation with SORAFENIB
0.1%
of all SORAFENIB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Reactive capillary endothelial proliferation From SORAFENIB?
Of the 5 reports.
Is Reactive capillary endothelial proliferation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SORAFENIB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does SORAFENIB Cause?
Hepatocellular carcinoma (1,665)
Diarrhoea (1,611)
Off label use (1,587)
Fatigue (1,041)
Palmar-plantar erythrodysaesthesia syndrome (1,040)
Decreased appetite (906)
Death (904)
Asthenia (777)
Nausea (716)
Rash (613)
What Other Drugs Cause Reactive capillary endothelial proliferation?
CAMRELIZUMAB (41)
CAPECITABINE (19)
CISPLATIN (19)
DOCETAXEL\DOCETAXEL ANHYDROUS (17)
OXALIPLATIN (11)
ATEZOLIZUMAB (10)
BEVACIZUMAB (10)
PEMBROLIZUMAB (7)
SINTILIMAB (7)
TORIPALIMAB (6)
Which SORAFENIB Alternatives Have Lower Reactive capillary endothelial proliferation Risk?
SORAFENIB vs SORGHUM HALEPENSE POLLEN
SORAFENIB vs SOTAGLIFLOZIN
SORAFENIB vs SOTALOL
SORAFENIB vs SOTATERCEPT
SORAFENIB vs SOTATERCEPT-CSRK